Literature DB >> 3492982

Regional brain function in schizophrenia. I. A positron emission tomography study.

R E Gur, S M Resnick, A Alavi, R C Gur, S Caroff, R Dann, F L Silver, A J Saykin, J B Chawluk, M Kushner.   

Abstract

Local cerebral glucose metabolism was determined with 18-F-fluorodeoxyglucose using positron emission tomography in a sample of 12 unmedicated schizophrenics and 12 matched normal controls. The data were analyzed for absolute metabolic rates and region/whole-brain ratios using the cortical-subcortical, antero-posterior, and laterality dimensions. Lobar areas within cortical regions were also compared. Across groups, subcortical metabolism was higher than cortical metabolism. Patients had lower metabolism, cortically and subcortically, and a steeper subcortical to cortical gradient. Patients with higher scores on the Brief Psychiatric Rating Scale had higher absolute metabolism and higher left relative to right hemispheric metabolism than did patients with lesser severity. The results did not show "hypofrontality" in schizophrenia. These findings provide some support for cerebral dysfunction in schizophrenia and indicate the need for further examination of the cortical-subcortical dimension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492982     DOI: 10.1001/archpsyc.1987.01800140021003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  21 in total

Review 1.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 2.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 3.  Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism.

Authors:  J D Ragland; J Yoon; M J Minzenberg; C S Carter
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 4.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

5.  Sex differences in brain-behavior relationships between verbal episodic memory and resting regional cerebral blood flow.

Authors:  J D Ragland; A R Coleman; R C Gur; D C Glahn; R E Gur
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

Review 6.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

7.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

Authors:  M Soyka; W Koch; H J Möller; T Rüther; K Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-18       Impact factor: 5.270

8.  An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Authors:  Abass Alavi; Søren Hess; Thomas J Werner; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

9.  Regional brain metabolism in schizophrenia: An FDG-PET study.

Authors:  R Seethalakshmi; S R Parkar; N Nair; S A Adarkar; A G Pandit; S A Batra; N S Baghel; S H Moghe
Journal:  Indian J Psychiatry       Date:  2006-07       Impact factor: 1.759

10.  Anatomical characteristics of the corpus callosum and clinical correlates in schizophrenia.

Authors:  C Colombo; A Bonfanti; S Scarone
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.